A Case of Internal Carotid Artery Thrombosis associated with Thalidomide Administration in Multiple Myeloma
Thalidomide is an effective chemotherapeutic agent used to achieve remission in multiple myeloma. However, its administration is associated with several adverse effects including venous thromboembolism, while arterial thrombosis has also, although rarely, been described in the literature. We report...
Main Authors: | Maria Angela Grima, David James Camilleri |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2016-06-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | http://ejcrim.com/index.php/EJCRIM/article/view/410 |
Similar Items
-
Thalidomide: near complete regression of extramedullary bulk in refractory multiple myeloma
by: A Anagnostara, et al.
Published: (2001-03-01) -
Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients
by: Priscilla Cury de Camargo Cury, et al.
Published: (2020-04-01) -
Reversible Pulmonary Hypertension Related to Thalidomide Treatment for Multiple Myeloma
by: Antonio Villa, et al.
Published: (2011-09-01) -
Thalidomide and its analogues in the treatment of Multiple Myeloma
by: Latif Tahir, et al.
Published: (2012-09-01) -
Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide
by: T.B.M. Castro, et al.
Published: (2016-01-01)